New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma
NCT00933673
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
76
Enrollment
OTHER
Sponsor class
Conditions
Lymphoma
Interventions
DRUG:
L-asp, DXM, IFO, VP-16, DDP
Sponsor
Fudan University